Chiniofon

Chiniofon is a medication that was historically used in the treatment of amoebiasis, an infection caused by Entamoeba histolytica. It is a compound that contains 8-hydroxyquinoline sulfate and sodium bicarbonate. Chiniofon was primarily used before the advent of more modern treatments for amoebiasis.
History[edit]
Chiniofon was introduced in the early 20th century as a treatment for amoebiasis. It was one of the first effective treatments available for this condition, which was a significant health problem in many parts of the world. The use of Chiniofon declined with the development of more effective and safer medications, such as metronidazole.
Mechanism of Action[edit]
The exact mechanism of action of Chiniofon is not well understood. However, it is believed that the 8-hydroxyquinoline component has antimicrobial properties that help to kill the Entamoeba histolytica organisms. The sodium bicarbonate component acts as an antacid, which may help to alleviate some of the gastrointestinal symptoms associated with amoebiasis.
Usage[edit]
Chiniofon was administered orally in the form of tablets or powder. The typical dosage varied depending on the severity of the infection and the patient's response to the treatment. It was often used in combination with other medications to enhance its effectiveness.
Side Effects[edit]
The use of Chiniofon was associated with several side effects, including gastrointestinal disturbances such as nausea, vomiting, and diarrhea. In some cases, patients experienced allergic reactions or skin rashes. Due to these side effects and the availability of better alternatives, Chiniofon is no longer commonly used.
Current Status[edit]
Chiniofon has largely been replaced by more effective and safer treatments for amoebiasis, such as metronidazole and tinidazole. These modern medications have a better safety profile and are more effective in eradicating the infection.
See Also[edit]
References[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
